What’s new in the world of synthetic blood, and how a bacterium evolves into a killer

Science Magazine Podcast

Science Podcast

News Commentary, News, Science

4.2 • 791 Ratings

🗓️ 4 July 2024

⏱️ 32 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

First up this week, guest host Kevin McLean talks to freelance writer Andrew Zaleski about recent advancements in the world of synthetic blood. They discuss some of the failed attempts over the past century that led many to abandon the cause altogether, and a promising new option in the works called ErythroMer that is both shelf stable and can work on any blood type. Next on the episode, producer Zakiya Whatley talks to Aaron Weimann from the University of Cambridge about the evolutionary history of the deadly bacterial pathogen Pseudomonas aeruginosa. They discuss how more than a century’s worth of samples from all over the world contributed to new insights on the emergence and expansion of the pathogen known for its ability to develop antimicrobial resistance. This week’s episode was produced with help from Podigy. About the Science Podcast Authors: Kevin McLean, Andrew Zaleski, Zakiya Whatley Episode Page: https://www.science.org/doi/10.1126/science.z1jhbqi About the Science Podcast: https://www.science.org/content/page/about-science-podcast [Image: Matt Roth, Music: Jeffrey Cook and Nguyen Khoi Nguyen] Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	This podcast is supported by the Icon School of Medicine at Mount Sinai, one of America's leading
0:05.8	research medical schools. Icon Mount Sinai is the academic arm of the eight hospital
0:11.1	Mount Sinai health system in New York City. It's consistently among the top recipients of
0:16.4	NIH funding. Researchers at Icon Mount Sinai have made breakthrough discoveries in many fields vital
0:22.8	to advancing the health of patients, including cancer, COVID and long COVID, cardiology,
0:29.3	neuroscience, and artificial intelligence. The Icon School of Medicine at Mount Sinai, we find a way.
0:36.7	Morgan State University, a Baltimore, Maryland, Carnegie
0:39.7	R2 doctoral research institution, offers more than 100 academic programs and awards degrees
0:45.8	at the baccalaureate, master's, and doctoral levels, is furthering their mission of growing the
0:50.8	future leading the world. Morgan continues to address the needs and challenges
0:55.2	of the modern urban environment.
0:57.4	With a four-year quadrupling of research,
1:00.0	more than a dozen new doctoral programs,
1:02.4	and eight new National Centers of Excellence,
1:05.1	Morgan is positioned to achieve Carnegie R1 designation
1:08.2	in the next five years.
1:10.4	To learn more about Morgan and their ascension to R1, visit the next five years. To learn more about Morgan and their
1:12.3	ascension to R1, visit morgan.edu slash research.
1:22.1	This is the science podcast for July 5th, 2024. I'm Kevin McLean, filling in for Sarah Crespi. First up this week,
1:30.1	freelance writer Andrew Zaleski joins me to talk about recent advancements in creating synthetic
1:35.5	blood. We discussed some of the failed attempts over the past century and how a new shelf-stable
1:41.0	candidate called erythramer could be a critical emergency substitute for any blood type.
	...

Transcript will be available on the free plan in -269 days. Upgrade to see the full transcript now.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Science Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Science Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.